Alcon Company Profile

✉ Email this page to a colleague

ALCON has fifty-seven approved drugs.

There are thirty-nine US patents protecting ALCON drugs. There is one tentative approval on ALCON drugs.

There are two hundred and seventeen patent family members on ALCON drugs in thirty-one countries and seventy-eight supplementary protection certificates in fourteen countries.

International Patents:	217
US Patents:	39
Tradenames:	48
Ingredients:	40
NDAs:	57
Patent Litigation for Alcon:	See patent lawsuits for Alcon
PTAB Cases with Alcon as patent owner:	See PTAB cases with Alcon as patent owner

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Alcon Labs Inc	RHOPRESSA	netarsudil mesylate	SOLUTION/DROPS;OPHTHALMIC	208254-001	Dec 18, 2017		RX	Yes	Yes	11,021,456	⤷ Try a Trial				⤷ Try a Trial
Alcon Pharms Ltd	NEOMYCIN SULFATE-DEXAMETHASONE SODIUM PHOSPHATE	dexamethasone sodium phosphate; neomycin sulfate	SOLUTION/DROPS;OPHTHALMIC	062714-001	Jul 21, 1986		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Alcon Labs Inc	EYSUVIS	loteprednol etabonate	SUSPENSION/DROPS;OPHTHALMIC	210933-001	Oct 26, 2020		RX	Yes	Yes	10,646,436	⤷ Try a Trial	Y			⤷ Try a Trial
Alcon Labs Inc	CYCLOGYL	cyclopentolate hydrochloride	SOLUTION/DROPS;OPHTHALMIC	084110-001	Approved Prior to Jan 1, 1982	AT	RX	Yes	Yes		⤷ Try a Trial				⤷ Try a Trial
Alcon	ISOPTO CETAPRED	prednisolone acetate; sulfacetamide sodium	SUSPENSION;OPHTHALMIC	087547-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Alcon	MYDRIACYL	tropicamide	SOLUTION/DROPS;OPHTHALMIC	012111-004	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Alcon Pharms Ltd	BETAXON	levobetaxolol hydrochloride	SUSPENSION/DROPS;OPHTHALMIC	021114-001	Feb 23, 2000	4,911,920*PED	⤷ Try a Trial
Alcon Pharms Ltd	NAVSTEL	calcium chloride; dextrose; magnesium chloride; oxiglutatione; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate	SOLUTION;IRRIGATION	022193-001	Jul 24, 2008	7,084,130	⤷ Try a Trial
Alcon Labs Inc	PATADAY TWICE DAILY RELIEF	olopatadine hydrochloride	SOLUTION/DROPS;OPHTHALMIC	020688-001	Dec 18, 1996	4,871,865	⤷ Try a Trial
Alcon Labs Inc	PATADAY ONCE DAILY RELIEF	olopatadine hydrochloride	SOLUTION/DROPS;OPHTHALMIC	021545-001	Dec 22, 2004	5,641,805*PED	⤷ Try a Trial
Alcon	BSS PLUS	calcium chloride; dextrose; glutathione disulfide; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate	SOLUTION;IRRIGATION	018469-001	Approved Prior to Jan 1, 1982	4,443,432	⤷ Try a Trial
Alcon Pharms Ltd	BETAXON	levobetaxolol hydrochloride	SUSPENSION/DROPS;OPHTHALMIC	021114-001	Feb 23, 2000	5,540,918*PED	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Ophthalmic Solution	0.03%	➤ Subscribe	2004-12-23
➤ Subscribe	Ophthalmic Solution	0.00%	➤ Subscribe	2008-11-28

Subscribe to access the full database, or Try a Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2957286	2018C/047	Belgium	⤷ Try a Trial	PRODUCT NAME: PATIROMER SORBITEX CALCIUM; AUTHORISATION NUMBER AND DATE: EU/1/17/1179 20170721
1280520	300722	Netherlands	⤷ Try a Trial	PRODUCT NAME: TOBRAMYCINE OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: C(2011)5394 20110720
1631293	92462	Luxembourg	⤷ Try a Trial	PRODUCT NAME: BRIMONIDINE ET SES SELS PHARMACEUTIQUES POUR L UTILISATION COMME MEDICAMENT POUR LE TRAITEMENT DES ROUGEURS INDUITES PAR LA ROSACEA.FIRST REGISTRATION: 20140225
1631293	C300683	Netherlands	⤷ Try a Trial	PRODUCT NAME: BRIMONIDINE EN FARMACEUTISCH AANVAARDBARE ZOUTEN DAARVAN VOOR TOEPASSING ALS GENEESMIDDEL VOOR DE BEHANDELING VAN DOOR ROSACEA GEINDUCEERDE ROODHEID; REGISTRATION NO/DATE: EU/1/13/904 20140225
1920764	1290027-0	Sweden	⤷ Try a Trial	PRODUCT NAME: TRAVOPROST
1631293	2014C/042	Belgium	⤷ Try a Trial	PRODUCT NAME: MIRVASO (BRIMONIDINE) EN FARMACEUTISCHE ZOUTEN DAARVAN VOOR GEBRUIK ALS MEDICIJN VOOR HET BEHANDELEN VAN ROSACEA GEINDUCEERDE ROODHEID; AUTHORISATION NUMBER AND DATE: EU/1/13/904 20140221
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.